Director/PDMR Shareholding

RNS Number : 5563Y

Hikma Pharmaceuticals Plc

22 August 2018

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	Chief Strategy and Corporate Development Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 30,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)	Price(s) and volume(s)	Price(s): £19.17 Volume(s): 30,000
d)	Aggregated information	Aggregated volume: 30,000 Price: £575,100
e)	Date of the transaction	20 to 21 August 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

22 August 2018

 

END

 

 

DSHGIGDICXDBGID